Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. II. Release of albumin in vitro

J Biomed Mater Res B Appl Biomater. 2005 Feb 15;72(2):299-304. doi: 10.1002/jbm.b.30156.

Abstract

Carboxymethyl konjac glucomannan-chitosan (CKGM-CS) nanoparticles were spontaneously prepared under very mild conditions via polyelectrolyte complexation. Bovine serum albumin (BSA), as a model protein drug, was incorporated into the CKGM-CS nanoparticles. The physicochemical properties of the BSA-loaded nanoparticles were identified by Zetasizer 3000 and FTIR spectrophotometry. Their sizes were from 330 nm to 900 nm; zeta potentials were positive according to varies CKGM/CS ratios. The encapsulation efficiency was up 20%. The release behavior in vitro of BSA from the nanoparticles was also investigated. We could find that the BSA release from the CKGM-CS nanoparticles is much more influenced by the CS coating layer than by the CKGM inner structure. And the CKGM-CS matrices not only exhibited pH-responsive properties, but ionic strength-sensitive properties. These systems may present a potential for pulsatile protein drug delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Delayed-Action Preparations / chemistry*
  • Drug Carriers / chemistry
  • Drug Delivery Systems / methods
  • Drug Delivery Systems / standards
  • Hydrogen-Ion Concentration
  • Kinetics
  • Mannans / chemistry*
  • Mannans / therapeutic use
  • Materials Testing*
  • Nanostructures / chemistry*
  • Osmolar Concentration
  • Particle Size
  • Polymers
  • Proteins / administration & dosage*
  • Serum Albumin / administration & dosage
  • Static Electricity

Substances

  • Delayed-Action Preparations
  • Drug Carriers
  • Mannans
  • Polymers
  • Proteins
  • Serum Albumin
  • (1-6)-alpha-glucomannan